Navigation Links
Medifast Announces First Quarter 2008 Financial Results

Reports Record Quarterly Sales of over $25 million

OWINGS MILLS, Md., May 12 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) announced today first quarter financial results for the period ended March 31, 2008.

Financial highlights included:

-- First quarter revenues increased 25%;

-- Gross margins increased to 75.8% vs. 74.8%

-- The direct sales segment of Take Shape for Life experienced sales

increase of 63% year-over-year;

-- Medifast Weight Control Centers quarterly revenues increased 75%;

For the first quarter Medifast reported revenue of $25.2 million, a 25% increase from $20.1 million in the first quarter of 2007. The Company reported net income of $1.4 million or $0.10 per basic and diluted share compared with $1.4 million, or $0.11 per basic share - $0.10 per diluted share in the first quarter of 2007.

The Company's balance sheet remains strong with stockholders' equity of $38.6 million and working capital of $9.8 million as of March 31, 2008. The current ratio was 2.3 to 1.

"We are pleased with the results of the quarter," commented Michael S. McDevitt, chief executive officer of Medifast, Inc. "Our multi-channel distribution model continues to gain traction, with virtually all of our channels achieving solid double-digit growth for the quarter. The Take Shape for Life division grew 63% year-over-year; and now represents approximately 39% of overall revenues for the first quarter. This growth can largely be attributed to the investments made during 2007 in the tools and training to promote growth in the recruiting of health coaches. In that regard, the number of active health coaches grew to 2,200 at the end of the first quarter of 2008 as compared to 1,350 for the same time period in 2007, an increase of 63%. We believe that the growth in health coach activity is a positive trend that should continue, and will lead to significant revenue growth in the near future."

Mr. McDevitt continued, "Our Medifast Weight Control Centers experienced revenue growth of 75% versus last year's comparable quarter. We are particularly pleased with the average monthly revenue per clinic growing 35%, to $39,000 per clinic in the first quarter from $29,000 in the first quarter last year. In the more established Dallas market, average monthly revenue per clinic is approximately $50,000. We believe that the recent growth in the Medifast Weight Control Centers validates our model and confirms the high demand from this segment of the weight loss market. During the first quarter we opened four additional corporate owned clinics in the Houston market and we plan on opening four additional corporate owned clinics in the Houston market by the end of the second quarter of 2008. We also expect to further develop the Dallas market by opening two additional clinics. Although we are in the very early stages of developing this channel, we are heartened by the consumer response."

"During the quarter," Mr. McDevitt continued, "Medifast Direct Response increased revenues by 6%. The engine that drives product sales in this business is advertising spend. Commencing this month, we have realigned our advertising spend between the different media types. In the first quarter of 2008, we assessed the return to spend on each advertising medium which has changed since prior year. We have made adjustments to the allocation of our advertising dollars between print, TV, and web and believe we will see the benefit of these changes in the coming quarters of 2008. Additionally, we will continue to generate revenue by expanding our client base through remarketing efforts such as direct mail and e-mail campaigns. The umbrella of national brand awareness generated by our direct response advertising drives business across our multi-channeled platform by fueling customers and business leads to Take Shape for Life and creating walk-ins to Medifast Weight Control Centers. The Company provides customers many options for support on our clinically proven weight loss program. The solutions that we provide to consumers dedicated to improving their quality of life have proven to be effective and we are dedicated to delivering our value proposition to the market in the most efficient and cost-effective manner possible."

Gross margins increased to 75.8% from 74.8% for the first quarter of 2008 compared with a year ago. The gross margin improved due to efficiencies gained from new machinery purchases in prior year as well as new shipping rules that resulted in additional shipping revenue from customers netting against shipping expense

2008 Full-Year Guidance

Management reiterates expectations of revenue growth for full-year 2008 in the range of 8-10%; and diluted earnings per share growth in the range of 30-35% for the year ended December 31, 2008.

First Quarter 2008 Conference Call

Interested parties can access the call by dialing (877) 407-8031 or (201) 689-8031, or can listen via a live Internet web cast, which can be found at in the section marked "Investor Relations." A replay of the call is available via web cast at until August 12, 2008 or by playback at (877) 660-6853 or (201) 612-7415 through June 12, 2008. Please use account #286 and conference id #282077 for the replay.

About Medifast:

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. Medifast is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medically supervised Medifast Weight Control Centers, and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast's believes that the expectations, statements, and assumptions reflected in these forward- looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contact: Brendan Connors Lytham Partners, LLC

Vice President - Finance Joe Diaz

410-581-8042 Joe Dorame Robert Blum




March 31, 2008 December 31, 2007

(Unaudited) (Audited)


Current assets:

Cash and cash equivalents $1,407,000 $2,195,000

Accounts receivable-net of

allowance for doubtful accounts of

$100,000 475,000 493,000

Inventory 9,973,000 9,181,000

Investment securities 1,405,000 1,439,000

Deferred compensation 723,000 814,000

Prepaid expenses and other current

assets 3,245,000 2,727,000

Prepaid income tax 143,000 -

Note receivable - current 180,000 180,000

Deferred tax asset 82,000 100,000

Total Current Assets 17,633,000 17,129,000

Property, plant and equipment - net 19,150,000 17,031,000

Trademarks and intangibles - net 6,897,000 7,356,000

Deferred tax asset, net of current

portion 897,000 897,000

Note receivable, net of current

portion 1,180,000 1,212,000

Other assets 301,000 99,000

TOTAL ASSETS $46,058,000 $43,724,000


Current liabilities:

Accounts payable and accrued

expenses $5,382,000 $4,279,000

Income taxes payable - 592,000

Line of credit 2,176,000 1,599,000

Current maturities of long-term

debt 257,000 264,000

Total Current Liabilities 7,815,000 6,734,000

Long-term debt, net of current

portion 4,505,000 4,570,000

Total Liabilities 12,320,000 11,304,000

Stockholders' Equity:

Common stock; par value $.001 per

share; 20,000,000 authorized;

13,814,098 and 13,709,098 shares

issued and outstanding,

respectively 14,000 14,000

Additional paid-in capital 27,225,000 26,953,000

Accumulated other comprehensive

income 154,000 321,000

Retained Earnings 11,183,000 9,818,000

38,576,000 37,106,000

Less: cost of 270,534 and 270,534

shares of common stock in treasury (1,971,000) (1,971,000)

Less: unearned compensation (2,867,000) (2,715,000)

Total Stockholders' Equity 33,738,000 32,420,000


EQUITY $46,058,000 $43,724,000



Three Months Ended March 31,


2008 2007

(Unaudited) (Unaudited)

Revenue, net $25,169,000 $20,089,000

Cost of sales 6,100,000 5,058,000

Gross Profit 19,069,000 15,031,000

Selling, general, and administration 17,007,000 13,117,000

Income from operations 2,062,000 1,914,000

Other income/(expense)

Interest expense (103,000) (95,000)

Interest income 38,000 33,000

Other expense 36,000 51,000

(29,000) (11,000)

Net income before provision for

income taxes 2,033,000 1,903,000

Provision for income tax (expense) (668,000) (530,000)

Net income $1,365,000 $1,373,000

Basic earnings per share $0.10 $0.11

Diluted earnings per share $0.10 $0.10

Weighted average shares outstanding -

Basic 13,101,157 12,899,543

Diluted 13,799,293 13,690,788

SOURCE Medifast, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medifast Announces Year-end 2007 Financial Results
2. Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008
3. Medifast Franchise Systems Sells First Territory in Baltimore
4. Medifast Offers 5 Heart Healthy Tips in Recognition of Fridays National Wear Red Day
5. Medifast Offers Stranded Pure Weight Loss Clients Unique Options
6. Medifast Receives Notice Regarding NYSE Listing
7. Medifast, Inc. Director of Research & Development Co-Authors Health Book
8. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
9. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
10. Medifast Announces Third-Quarter 2007 Results
11. Medifast Announces Updated Full Year 2007 Guidance
Post Your Comments:
(Date:5/27/2016)... SC (PRWEB) , ... May 27, 2016 , ... ... a line of classic American timber frame barn kits, which can be found on ... are inspired by historic American barn plans, and they highlight the craftsmanship of timber ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst ... third time to shed lights on the variety of topics detailing why we appreciate ... Appreciation” tackles why this career has gone from being in a major recession to ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought ... industry, from leading advocates, associations and industry leaders such as Bioness. , ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses ... human interest stories, courtesy of leaders in the nursing and health care industry. ... from leading advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett ...
(Date:5/27/2016)... ... ... With a team of certified experts, Validation Center is ... GMP accreditation, Validation Center is also a registered authority of the international system ... Validation Center is ISO17025 accredited and only offers its clients the latest technology, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... LabStyle Innovations Corp . ( NASDAQ: DRIO ... that the Company,s Chief Financial Officer, Zvi Ben-David ... 1-2 in New York, NY and ... Los Angeles, CA. During his ... including the U.S. FDA Clearance and commercial launch of the ...
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... -- According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - ... valued at US$ 5.89 Bn in 2014 and is anticipated ... 2023 to reach US$ 7.99 Bn in 2023. ... free drug delivery devices and the market is estimated based ...
Breaking Medicine Technology: